1	Transactivation	Transactivation	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	interleukin-1alpha	interleukin-1alpha	_	_	_	_	_	_	_
5	promoter	promoter	_	_	_	_	_	_	_
6	by	by	_	_	_	_	_	_	_
7	human	human	_	_	_	_	_	_	_
8	T-cell	t-cell	_	_	_	_	_	_	_
9	leukemia	leukemia	_	_	_	_	_	_	_
10	virus	virus	_	_	_	_	_	_	_
11	type	type	_	_	_	_	_	_	_
12	I	i	_	_	_	_	_	_	_
13	and	and	_	_	_	_	_	_	_
14	type	type	_	_	_	_	_	_	_
15	II	ii	_	_	_	_	_	_	_
16	Tax	Tax	_	_	_	_	_	_	_
17	proteins	protein	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	Human	human	_	_	_	_	_	_	_
2	T-cell	T-cell	_	_	_	_	_	_	_
3	leukemia	leukemia	_	_	_	_	_	_	_
4	virus	virus	_	_	_	_	_	_	_
5	type	type	_	_	_	_	_	_	_
6	I	i	_	_	_	_	_	_	_
7	(	(	_	_	_	_	_	_	_
8	HTLV-I)-infected	htlv-i)-infected	_	_	_	_	_	_	_
9	T-cell	t-cell	_	_	_	_	_	_	_
10	lines	line	_	_	_	_	_	_	_
11	constitutively	constitutively	_	_	_	_	_	_	_
12	produce	produce	_	_	_	_	_	_	_
13	high	high	_	_	_	_	_	_	_
14	levels	level	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	interleukin-1alpha	interleukin-1alpha	_	_	_	_	_	_	_
17	(	(	_	_	_	_	_	_	_
18	IL-1alpha	IL-1alpha	_	_	_	_	_	_	_
19	)	)	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	To	to	_	_	_	_	_	_	_
2	analyze	analyze	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	mechanisms	mechanism	_	_	_	_	_	_	_
5	that	that	_	_	_	_	_	_	_
6	lead	lead	_	_	_	_	_	_	_
7	to	to	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	expression	expression	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	IL-1alpha	IL-1alpha	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	HTLV-I-infected	htlv-i-infected	_	_	_	_	_	_	_
14	cell	cell	_	_	_	_	_	_	_
15	lines	line	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	we	we	_	_	_	_	_	_	_
18	studied	study	_	_	_	_	_	_	_
19	regulatory	regulatory	_	_	_	_	_	_	_
20	regions	region	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	human	human	_	_	_	_	_	_	_
24	IL-1alpha	IL-1alpha	_	_	_	_	_	_	_
25	promoter	promoter	_	_	_	_	_	_	_
26	involved	involve	_	_	_	_	_	_	_
27	in	in	_	_	_	_	_	_	_
28	activation	activation	_	_	_	_	_	_	_
29	of	of	_	_	_	_	_	_	_
30	the	the	_	_	_	_	_	_	_
31	IL-1alpha	IL-1alpha	_	_	_	_	_	_	_
32	gene	gene	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

1	IL-1alpha	IL-1alpha	_	_	_	_	_	_	_
2	promoter	promoter	_	_	_	_	_	_	_
3	constructs	construct	_	_	_	_	_	_	_
4	drive	drive	_	_	_	_	_	_	_
5	transcription	transcription	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	chloramphenicol	chloramphenicol	_	_	_	_	_	_	_
9	acetyltransferase	acetyltransferase	_	_	_	_	_	_	_
10	(	(	_	_	_	_	_	_	_
11	CAT	CAT	_	_	_	_	_	_	_
12	)	)	_	_	_	_	_	_	_
13	reporter	reporter	_	_	_	_	_	_	_
14	gene	gene	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	HTLV-I-positive	htlv-i-positive	_	_	_	_	_	_	_
17	MT-2	mt-2	_	_	_	_	_	_	_
18	cells	cell	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	which	which	_	_	_	_	_	_	_
21	constitutively	constitutively	_	_	_	_	_	_	_
22	produce	produce	_	_	_	_	_	_	_
23	IL-1alpha	IL-1alpha	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	a	a	_	_	_	_	_	_	_
3	cotransfection	cotransfection	_	_	_	_	_	_	_
4	assay	assay	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	Tax	Tax	_	_	_	_	_	_	_
8	protein	protein	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	both	both	_	_	_	_	_	_	_
11	HTLV-I	HTLV-I	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	HTLV-II	HTLV-II	_	_	_	_	_	_	_
14	specifically	specifically	_	_	_	_	_	_	_
15	activated	activate	_	_	_	_	_	_	_
16	transcription	transcription	_	_	_	_	_	_	_
17	from	from	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	IL-1alpha	IL-1alpha	_	_	_	_	_	_	_
20	promoter	promoter	_	_	_	_	_	_	_
21	in	in	_	_	_	_	_	_	_
22	an	an	_	_	_	_	_	_	_
23	uninfected	uninfected	_	_	_	_	_	_	_
24	Jurkat	Jurkat	_	_	_	_	_	_	_
25	cell	cell	_	_	_	_	_	_	_
26	line	line	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	A	a	_	_	_	_	_	_	_
2	mutant	mutant	_	_	_	_	_	_	_
3	Tax	tax	_	_	_	_	_	_	_
4	protein	protein	_	_	_	_	_	_	_
5	deficient	deficient	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	transactivation	transactivation	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	genes	gene	_	_	_	_	_	_	_
10	by	by	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	nuclear	nuclear	_	_	_	_	_	_	_
13	factor	factor	_	_	_	_	_	_	_
14	(	(	_	_	_	_	_	_	_
15	NF)-kappaB	NF)-kappaB	_	_	_	_	_	_	_
16	pathway	pathway	_	_	_	_	_	_	_
17	was	be	_	_	_	_	_	_	_
18	unable	unable	_	_	_	_	_	_	_
19	to	to	_	_	_	_	_	_	_
20	induce	induce	_	_	_	_	_	_	_
21	transcriptional	transcriptional	_	_	_	_	_	_	_
22	activity	activity	_	_	_	_	_	_	_
23	of	of	_	_	_	_	_	_	_
24	IL-1alpha	IL-1alpha	_	_	_	_	_	_	_
25	promoter-CAT	promoter-cat	_	_	_	_	_	_	_
26	constructs	construct	_	_	_	_	_	_	_
27	,	,	_	_	_	_	_	_	_
28	but	but	_	_	_	_	_	_	_
29	was	be	_	_	_	_	_	_	_
30	rescued	rescue	_	_	_	_	_	_	_
31	by	by	_	_	_	_	_	_	_
32	exogenous	exogenous	_	_	_	_	_	_	_
33	provision	provision	_	_	_	_	_	_	_
34	of	of	_	_	_	_	_	_	_
35	p65/p50	p65/p50	_	_	_	_	_	_	_
36	NF-kappaB	nf-kappab	_	_	_	_	_	_	_
37	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	found	find	_	_	_	_	_	_	_
3	that	that	_	_	_	_	_	_	_
4	two	two	_	_	_	_	_	_	_
5	IL-1alpha	IL-1alpha	_	_	_	_	_	_	_
6	kappaB-like	kappab-like	_	_	_	_	_	_	_
7	sites	site	_	_	_	_	_	_	_
8	(	(	_	_	_	_	_	_	_
9	positions	position	_	_	_	_	_	_	_
10	-1,065	-1,065	_	_	_	_	_	_	_
11	to	to	_	_	_	_	_	_	_
12	-1,056	-1,056	_	_	_	_	_	_	_
13	and	and	_	_	_	_	_	_	_
14	+646	+646	_	_	_	_	_	_	_
15	to	to	_	_	_	_	_	_	_
16	+655	+655	_	_	_	_	_	_	_
17	)	)	_	_	_	_	_	_	_
18	specifically	specifically	_	_	_	_	_	_	_
19	formed	form	_	_	_	_	_	_	_
20	a	a	_	_	_	_	_	_	_
21	complex	complex	_	_	_	_	_	_	_
22	with	with	_	_	_	_	_	_	_
23	NF-kappaB-containing	nf-kappab-containing	_	_	_	_	_	_	_
24	nuclear	nuclear	_	_	_	_	_	_	_
25	extract	extract	_	_	_	_	_	_	_
26	from	from	_	_	_	_	_	_	_
27	MT-2	mt-2	_	_	_	_	_	_	_
28	cells	cell	_	_	_	_	_	_	_
29	and	and	_	_	_	_	_	_	_
30	that	that	_	_	_	_	_	_	_
31	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
32	bound	bind	_	_	_	_	_	_	_
33	with	with	_	_	_	_	_	_	_
34	higher	high	_	_	_	_	_	_	_
35	affinity	affinity	_	_	_	_	_	_	_
36	to	to	_	_	_	_	_	_	_
37	the	the	_	_	_	_	_	_	_
38	3	3	_	_	_	_	_	_	_
39	’	'	_	_	_	_	_	_	_
40	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
41	binding	binding	_	_	_	_	_	_	_
42	site	site	_	_	_	_	_	_	_
43	than	than	_	_	_	_	_	_	_
44	to	to	_	_	_	_	_	_	_
45	the	the	_	_	_	_	_	_	_
46	5	5	_	_	_	_	_	_	_
47	’	'	_	_	_	_	_	_	_
48	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
49	site	site	_	_	_	_	_	_	_
50	.	.	_	_	_	_	_	_	_

1	Moreover	moreover	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	deletion	deletion	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	either	either	_	_	_	_	_	_	_
6	5	5	_	_	_	_	_	_	_
7	’	'	_	_	_	_	_	_	_
8	or	or	_	_	_	_	_	_	_
9	3	3	_	_	_	_	_	_	_
10	’	'	_	_	_	_	_	_	_
11	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
12	sites	site	_	_	_	_	_	_	_
13	reduced	reduce	_	_	_	_	_	_	_
14	IL-1alpha	IL-1alpha	_	_	_	_	_	_	_
15	promoter	promoter	_	_	_	_	_	_	_
16	activity	activity	_	_	_	_	_	_	_
17	in	in	_	_	_	_	_	_	_
18	MT-2	mt-2	_	_	_	_	_	_	_
19	cells	cell	_	_	_	_	_	_	_
20	and	and	_	_	_	_	_	_	_
21	transactivation	transactivation	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	IL-1alpha	IL-1alpha	_	_	_	_	_	_	_
25	promoter	promoter	_	_	_	_	_	_	_
26	by	by	_	_	_	_	_	_	_
27	exogenous	exogenous	_	_	_	_	_	_	_
28	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
29	and	and	_	_	_	_	_	_	_
30	Tax	Tax	_	_	_	_	_	_	_
31	in	in	_	_	_	_	_	_	_
32	Jurkat	Jurkat	_	_	_	_	_	_	_
33	cells	cell	_	_	_	_	_	_	_
34	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	data	datum	_	_	_	_	_	_	_
3	suggest	suggest	_	_	_	_	_	_	_
4	a	a	_	_	_	_	_	_	_
5	general	general	_	_	_	_	_	_	_
6	role	role	_	_	_	_	_	_	_
7	for	for	_	_	_	_	_	_	_
8	Tax	Tax	_	_	_	_	_	_	_
9	induction	induction	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	IL-1alpha	IL-1alpha	_	_	_	_	_	_	_
12	gene	gene	_	_	_	_	_	_	_
13	transcription	transcription	_	_	_	_	_	_	_
14	by	by	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
17	pathway	pathway	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	Expression	expression	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	IL-1alpha	IL-1alpha	_	_	_	_	_	_	_
4	by	by	_	_	_	_	_	_	_
5	HTLV-I	HTLV-I	_	_	_	_	_	_	_
6	productively	productively	_	_	_	_	_	_	_
7	infected	infected	_	_	_	_	_	_	_
8	cells	cell	_	_	_	_	_	_	_
9	may	may	_	_	_	_	_	_	_
10	be	be	_	_	_	_	_	_	_
11	important	important	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	hypercalcemia	hypercalcemia	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	osteolytic	osteolytic	_	_	_	_	_	_	_
17	bone	bone	_	_	_	_	_	_	_
18	lesions	lesion	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	neutrophilia	neutrophilia	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	elevation	elevation	_	_	_	_	_	_	_
23	of	of	_	_	_	_	_	_	_
24	C-reactive	c-reactive	_	_	_	_	_	_	_
25	protein	protein	_	_	_	_	_	_	_
26	,	,	_	_	_	_	_	_	_
27	and	and	_	_	_	_	_	_	_
28	fever	fever	_	_	_	_	_	_	_
29	frequently	frequently	_	_	_	_	_	_	_
30	seen	see	_	_	_	_	_	_	_
31	in	in	_	_	_	_	_	_	_
32	patients	patient	_	_	_	_	_	_	_
33	with	with	_	_	_	_	_	_	_
34	HTLV-I-induced	htlv-i-induced	_	_	_	_	_	_	_
35	adult	adult	_	_	_	_	_	_	_
36	T-cell	t-cell	_	_	_	_	_	_	_
37	leukemia/lymphoma	leukemia/lymphoma	_	_	_	_	_	_	_
38	.	.	_	_	_	_	_	_	_

